(Rac) -Brassinazole
(Rac) -Brassinazole, triazole-type compound, is a brassinosteroid (BR) biosynthesis inhibitor. (Rac) -Brassinazole increases inhibition of CYP90B in BR biosynthesis[1][2]
Product Specifications
CAS Number
[224047-41-0]
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/rac-brassinazole.html
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
OC(C1=CC=CC=C1)(C)C(CC2=CC=C(Cl)C=C2)N3N=CN=C3
Molecular Formula
C18H18ClN3O
Molecular Weight
327.81
Precautions
H315, H319
References & Citations
[1]Y K Min, et al. New Lead Compounds for Brassinosteroid Biosynthesis Inhibitors. Bioorg Med Chem Lett. 1999 Feb 8;9 (3) :425-30.|[2]Eriko Sasaki, et al. Uniconazole, a Cytochrome P450 Inhibitor, Inhibits Trans-Zeatin Biosynthesis in Arabidopsis. Phytochemistry. 2013 Mar;87:30-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
040040-FITC 200 µL
PIK3C2A, CT (PIK3C2A, Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha, Phosphoinositide 3-kinase-C2-alpha) (FITC) discontinued
Ask
View Details 